2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 24.441 | 21.540 | 37 | 37 | 36 | 8.157 | 19.981 | 17.234 | 20.172 | 25 |
Total Income - EUR | 24.441 | 21.540 | 37 | 37 | 36 | 8.157 | 19.981 | 17.234 | 22.135 | 25 |
Total Expenses - EUR | 26.068 | 21.577 | 1.743 | 6 | 0 | 1.467 | 2.607 | 2.237 | 2.379 | 24 |
Gross Profit/Loss - EUR | -1.628 | -36 | -1.706 | 31 | 36 | 6.690 | 17.373 | 14.997 | 19.755 | 1 |
Net Profit/Loss - EUR | -2.361 | -683 | -1.707 | 30 | 35 | 6.445 | 16.791 | 14.490 | 19.150 | 1 |
Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ingenium Pharm Med Srl
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 12.422 | 12.460 | 11.566 | 10.628 | 4.980 | 5.260 | 5.358 | 5.451 | 6.498 | 7.428 |
Current Assets | 3.517 | 5.838 | 5.878 | 5.821 | 5.750 | 8.676 | 20.603 | 10.328 | 30.337 | 28.552 |
Inventories | 773 | 572 | 617 | 607 | 595 | 1.098 | 1.385 | 2.013 | 2.560 | 2.552 |
Receivables | 2.465 | 5.259 | 5.249 | 5.165 | 5.064 | 7.575 | 19.194 | 8.313 | 27.748 | 25.860 |
Cash | 279 | 7 | 12 | 49 | 91 | 2 | 24 | 2 | 30 | 140 |
Shareholders Funds | 5.307 | 4.669 | 2.915 | 2.895 | 2.877 | 9.267 | 25.882 | 14.732 | 33.927 | 33.826 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 5.638 | 7.667 | 8.414 | 8.284 | 8.133 | 4.389 | 5.349 | 7.163 | 8.870 | 7.149 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4619 - 4619" | |||||||||
CAEN Financial Year | 4619 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.